Robert Sterling
Plus aucun poste en cours
Historique de carrière de Robert Sterling
Anciens postes connus de Robert Sterling
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Hoechst Roussel Vet Gmbh
 Hoechst Roussel Vet Gmbh Pharmaceuticals: OtherHealth Technology Part of Merck & Co., Inc., Hoechst Roussel Vet Gmbh develops pharmaceutical products for animals. The company is based in Hessen, Germany. Hoechst Roussel Vet was acquired by Intervet International BV from Hoechst AG on August 11, 1999 for $713.99 million. | Corporate Officer/Principal | - | - |
Bioenvision, Inc.
 Bioenvision, Inc. Medical/Nursing ServicesHealth Services Bioenvision, Inc. engages in the acquisition, development, distribution, and marketing of compounds and technologies for the treatment of cancer. It also develops anti-infective technologies, which includes the OLIGON(R) technology. The company was founded by Christopher B. Wood on August 16, 1996 and is headquartered in New York, NY. | Corporate Officer/Principal | 01/12/2001 | - |
Formation de Robert Sterling
| The Pennsylvania State University | Undergraduate Degree |
Statistiques
Internationale
| Etats-Unis | 3 |
| Allemagne | 2 |
Opérationnelle
| Corporate Officer/Principal | 2 |
| Undergraduate Degree | 1 |
Sectorielle
| Health Services | 2 |
| Consumer Services | 2 |
| Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Bioenvision, Inc.
Bioenvision, Inc. Medical/Nursing ServicesHealth Services Bioenvision, Inc. engages in the acquisition, development, distribution, and marketing of compounds and technologies for the treatment of cancer. It also develops anti-infective technologies, which includes the OLIGON(R) technology. The company was founded by Christopher B. Wood on August 16, 1996 and is headquartered in New York, NY. | Health Services |
Hoechst Roussel Vet Gmbh
Hoechst Roussel Vet Gmbh Pharmaceuticals: OtherHealth Technology Part of Merck & Co., Inc., Hoechst Roussel Vet Gmbh develops pharmaceutical products for animals. The company is based in Hessen, Germany. Hoechst Roussel Vet was acquired by Intervet International BV from Hoechst AG on August 11, 1999 for $713.99 million. | Health Technology |
- Bourse
- Insiders
- Robert Sterling
- Expérience
